
Q-Discover
Molecular design, protein folding, and computational chemistry for end-to-end drug discovery workflows.
Overview
Q-Discover is an end-to-end platform for modern drug discovery developed by Quantori, built on top of the Q-Scientist agentic AI framework. It is a comprehensive, modular platform designed specifically for life sciences organizations, addressing the limitations of generic AI tools by providing integrated, purpose-built capabilities for computational chemistry, molecular design, protein engineering, and multi-omics analysis. Q-Discover is intended for research scientists and R&D teams seeking to accelerate drug discovery workflows without requiring deep programming expertise.
The platform brings together siloed computational and biological data into a unified environment, enabling multi-modal data analysis and predictive modeling across the full drug discovery pipeline. It supports deployment as a dedicated SaaS solution or within a client's own infrastructure, giving organizations full control and ownership over their data and environment.
Core Scientific Capabilities
- LLM-Powered Biomarker Discovery: A multi-agent AI solution that automates complex workflows and integrates siloed clinical, genomic, and molecular data to accelerate research timelines.
- LLM-Powered PK/PD Platform: A multi-agent AI solution for pharmacokinetics and pharmacodynamics analysis, automating complex modeling routines and integrating fragmented clinical data.
- Computational Chemistry: High-performance pipelines for molecular dynamics, docking, virtual screening, and PK/PD modeling.
- AI-Driven Molecular Design: Leverages ML Conformer Generator APIs and graph-based models, including SMILES-to-graph conversion, to create and optimize novel 3D molecular structures.
- Protein Engineering and Modeling: Supports complex protein folding workflows such as AlphaFold, protein-ligand interaction modeling, and structure prediction through a streamlined user interface.
- Multi-Omics Integration: Provides tools for scalable processing and integration of heterogeneous data types including genomics, proteomics, and clinical data for holistic analysis.
Specialized R&D Workflows
- Target Identification and Validation: Automates the discovery process from fragmented data sources to identify and validate drug targets.
- Small Molecule Optimization: Enhances PK/PD modeling and dosing strategies to improve candidate molecules.
- Biomarker Discovery: Integrates clinical, molecular, and genomic data to identify key biological markers relevant to disease and treatment.
- Cryptic Pocket Discovery: Identifies hidden binding sites on proteins using advanced machine learning and biophysical simulations.
- Antibody Design: Supports optimized antibody design focused on improving binding affinity and reducing immunogenicity.
Scalable Cloud-Native Technical Foundation
- Cloud Agnostic Deployment: Supports seamless deployment across major cloud platforms including GCP, AWS, and Azure.
- HPC Optimization: Utilizes GCP Batch, Google Kubernetes Engine (GKE), and GPU/TPU virtual machines to handle massive computational jobs efficiently.
- Automated Infrastructure Setup: Managed services handle data storage and infrastructure deployment, minimizing IT overhead for research teams.
- Non-Programming Interface: An intuitive web application allows scientists to configure and run complex computational pipelines without requiring coding skills.
- Advanced 3D Visualization: Built-in visualization tools enable quick interpretation and validation of molecular models and experimental results.
Q-Discover is designed to meet the reliability and cost-efficiency demands of health and life sciences computation, offering flexible deployment options — including dedicated SaaS or on-premises within client infrastructure — to suit varying organizational requirements around data governance and control.
